Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of three experimental HIV vaccines in healthy adults
PACTR202006495409011Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jun 2020
- Modality
- Prophylactic Vaccines → Vaccines & Immunotherapeutics, DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Viral Vectors → Gene Addition/Replacement → Gene Therapies
- Countries
- 3
01
Overview
Phase 1, open-label trial of ChAdOx1.tHIVconsv1, MVA.tHIVconsv3 and MVA.tHIVconsv4 in human immunodeficiency virus infection (HIV) (2 arms), sponsored by University of Oxford. Started Jun 2020; status: completed.
02
Drugs
ChAdOx1.tHIVconsv1MVA.tHIVconsv3MVA.tHIVconsv4
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on PACTR202006495409011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006495409011.